Approximately 10% of Cystic Fibrosis (CF) patients, particularly those with CF transmembrane conductance regulator (CFTR) gene nonsense mutations, lack effective treatments. The potential of gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results